We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+0.8%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$796M
AUM Growth
-$185M
Cap. Flow
-$163M
Cap. Flow %
-20.42%
Top 10 Hldgs %
3.37%
Holding
1,987
New
622
Increased
338
Reduced
393
Closed
624

Top Sells

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$5.34M
2
MSFT icon
Microsoft
MSFT
+$5.22M
3
OPLN
Openlane
OPLN
+$4.6M
4
AAPL icon
Apple
AAPL
+$4.51M
5
HRI icon
Herc Holdings
HRI
+$4.09M

Sector Composition

Rank Sector Weight
1 Healthcare 16.45%
2 Industrials 15.7%
3 Technology 14.88%
4 Consumer Discretionary 11.13%
5 Financials 10.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CUE icon
151
Cue Biopharma
CUE
$113M
$1.13M 0.14%
3,327
-731
-18% -$283K
KRRO icon
152
Korro Bio
KRRO
$175M
$1.13M 0.14%
4,399
+2,766
+169% +$841K
KELYA icon
153
Kelly Services Class A
KELYA
$542M
$1.13M 0.14%
67,119
-13,369
-17% -$244K
COHU icon
154
Cohu
COHU
$2.45B
$1.12M 0.14%
29,517
-6,218
-17% -$213K
YMAB
155
DELISTED
Y-mAbs Therapeutics
YMAB
$1.12M 0.14%
+69,311
New +$1.48M
KLAC icon
156
KLA
KLAC
$252B
$1.12M 0.14%
26,060
-26,760
-51% -$1.03M
FOXF icon
157
Fox Factory Holding Corp
FOXF
$791M
$1.12M 0.14%
6,581
-684
-9% -$114K
IIIV icon
158
i3 Verticals
IIIV
$429M
$1.12M 0.14%
49,074
+5,936
+14% +$133K
QNCX icon
159
Quince Therapeutics
QNCX
$28.9M
$1.12M 0.14%
443
+368
+491% +$2.25M
TG icon
160
Tredegar Corp
TG
$270M
$1.12M 0.14%
94,473
+41,466
+78% +$500K
HCC icon
161
Warrior Met Coal
HCC
$4.73B
$1.11M 0.14%
43,279
-32,020
-43% -$770K
MTDR icon
162
Matador Resources
MTDR
$6.04B
$1.11M 0.14%
30,039
-32,075
-52% -$1.31M
SAGE
163
DELISTED
Sage Therapeutics
SAGE
$1.11M 0.14%
26,035
+17,664
+211% +$740K
OXM icon
164
Oxford Industries
OXM
$560M
$1.11M 0.14%
+10,891
New +$1.06M
BRKL
165
DELISTED
Brookline Bancorp
BRKL
$1.1M 0.14%
68,146
+48,348
+244% +$771K
ARI
166
Apollo Commercial Real Estate
ARI
$876M
$1.1M 0.14%
+83,719
New +$1.21M
CERS icon
167
Cerus
CERS
$468M
$1.1M 0.14%
161,830
+72,453
+81% +$488K
ASND icon
168
Ascendis Pharma A/S
ASND
$16.4B
$1.1M 0.14%
+8,175
New +$1.22M
WTI icon
169
W&T Offshore
WTI
$497M
$1.1M 0.14%
339,974
-120,571
-26% -$464K
NS
170
DELISTED
NuStar Energy L.P.
NS
$1.1M 0.14%
+69,170
New +$1.07M
BBSI icon
171
Barrett Business Services
BBSI
$813M
$1.09M 0.14%
63,172
+4,184
+7% +$79.4K
HZO icon
172
MarineMax
HZO
$776M
$1.09M 0.14%
+18,395
New +$985K
UFI icon
173
UNIFI
UFI
$128M
$1.08M 0.14%
46,875
-23,332
-33% -$532K
ATSG
174
DELISTED
Air Transport Services Group
ATSG
$1.08M 0.14%
36,743
-30,514
-45% -$812K
SIEN
175
DELISTED
Sientra, Inc.
SIEN
$1.08M 0.14%
+29,438
New +$1.43M

Similar funds

GSA Capital Partners's Q4 2021 Portfolio in Review

As of Q4 2021, GSA Capital Partners held 1,987 positions worth $796M, down 19% from $982M the previous quarter. Its ten largest holdings account for 3.4% of the portfolio.

GSA Capital Partners withdrew a net $163M in Q4 2021, closing 624 positions and reducing 393 holdings. Its most notable exit was Morgan Stanley, an estimated $5.34M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.

Against the trend, GSA Capital Partners opened a new position in Genius Sports worth $2.45M.

  • GSA Capital Partners's largest Q4 2021 buy was Genius Sports: 322,717 shares worth $2.45M.
  • GSA Capital Partners added most to State Street Consumer Staples Select Sector SPDR ETF in Q4 2021, an estimated $2.43M increase.
  • GSA Capital Partners's biggest Q4 2021 reduction was Microsoft, cutting an estimated $5.22M.
  • GSA Capital Partners fully exited Morgan Stanley in Q4 2021, selling an estimated $5.34M.
  • GSA Capital Partners's ten largest holdings make up 3.4% of its $796M portfolio in Q4 2021.
  • GSA Capital Partners opened 622 new positions and closed 624 in Q4 2021.
  • GSA Capital Partners's portfolio value fell 19% quarter-over-quarter to $796M.

Based on GSA Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.